What question did this study set out to answer?

To evaluate the long-term outcomes of sclerotherapy using glucose versus polidocanol for treating telangiectasias and reticular veins.

March 26, 2026

Long-term follow-up of sclerotherapy of telangiectasias and reticular veins in lower limbs: Glucose versus polidocanol diluted in glucose

Key Points

To evaluate the long-term outcomes of sclerotherapy using glucose versus polidocanol for treating telangiectasias and reticular veins.
Follow-up for 3 years post-sclerotherapy treatment
Assessment of telangiectasia and reticular vein recurrence
Evaluation of pigmentation resolution and matting persistence
Telangiectasia recurrence was common after three years regardless of treatment
Reticular veins had minimal recurrence, particularly with polidocanol
Pigmentation generally resolved spontaneously after treatment
Matting persisted longer in telangiectasias compared to reticular veins

Abstract

Telangiectasia recurrence was common after 3 years, regardless of treatment. In contrast, reticular veins showed minimal recurrence, particularly with PDHG. Pigmentation generally resolved spontaneously. Matting was more persistent in telangiectasias than in reticular veins. These findings support the long-term viability of both approaches in clinical practice.

Bookmark

Cite This Study

Bertanha et al. (Mon,) studied this question.

synapsesocial.com/papers/69c4cda5fdc3bde44891a3bf https://doi.org/https://doi.org/10.1177/1358863x251412739

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark